Project Grant R03CA277198
Award Date
7/8/24
Completion Date
6/30/26
Dollars Obligated
$161K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Storrs, CT 06269, USA
Similar Awards
This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $182,236 to New York University School of Medicine to adapt and pilot test an evidence-based sexual health communication skills training intervention for prostate cancer patients. The key products and services to be delivered include: Conducting focus groups with prostate cancer patients and interviews with providers to identify barriers and facilitators to patient-provider communication...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) provides $273,211 to Connecticut Children's Medical Center to develop, refine, and assess a novel web-based intervention called the Reproductive and Sexual Health Patient Education and Communication Tool (RESPECT). The goal of RESPECT is to improve sexual and reproductive health communication between adolescent and young adult (AYA) oncology patients and their clinicians. The 5-year...
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will provide $402,401 to the University of Missouri System to conduct a pilot study on the feasibility and impact of a metacognitive strategy training (MCST) intervention for women with cancer-related cognitive impairment (CRCI) following breast cancer treatment. The study aims to examine the effects of MCST on cognitive performance, frontoparietal neural functioning, and functional...
This $162,190 federal Project Grant award from the National Institute of Nursing Research (NINR) under CFDA 93.361 Nursing Research supports the development and pilot testing of a peer-led, web-based psychosocial support intervention for Black breast cancer survivors. The primary goal is to examine the feasibility, acceptability, and preliminary efficacy of the intervention in reducing distress and improving health-related quality of life among this population, who experience...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $858,166 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct a randomized clinical trial of a targeted palliative care intervention for patients with metastatic breast cancer. The 5-year study aims to improve documentation of end-of-life care preferences, delivery of end-of-life care, and patient-reported outcomes for this...
This $1,500,000 Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will support research by the University of Rochester to elucidate how key aspects of social connectedness, including structural characteristics, functional aspects, and quality of relationships in the social networks of older adults with advanced cancer, interact and influence end-of-life health behaviors. The study will focus on three critical behaviors - serious illness...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $398,207 to The Washington University in St. Louis to develop and test a multilevel intervention to improve interdisciplinary communication quality in low-resource pediatric oncology hospitals. The project aims to: 1) evaluate the relationship between communication quality and structure around patient deterioration, 2) identify strategies to improve communication...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $318,589 to Oregon State University to conduct a pilot trial of the "Mindful After Cancer (MAC)" virtual intervention. The goal is to evaluate the feasibility and acceptability of the MAC intervention, which aims to promote sexual health among breast and gynecologic cancer survivors. The project will also identify contextual factors that may impact the...
This $1,073,982 National Cancer Institute project grant will fund research at Washington University in University City, Missouri from January 2023 through December 2027 under the Cancer Cause and Prevention Research program (CFDA 93.393). The research aims to document unmet social needs among 300 patient-caregiver dyads where the patient has breast or gynecologic cancer. It will analyze how social needs affect biopsychosocial outcomes for patients and caregivers, including depressive symptoms,...
This $656,014 Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will fund a randomized clinical trial at The Ohio State University to evaluate the effectiveness of a telemedicine-mHealth symptom management intervention, called FOCUS, for advanced cancer patients in underserved rural communities. The FOCUS intervention aims to improve a symptom cluster including sleep difficulties, anxiety, depression, and fatigue, and enhance functional...